deltatrials
Active Not Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03753204

Salt-Sensitivity and Immunity Cell Activation

Sponsor: Vanderbilt University Medical Center

Conditions High Blood Pressure Inflammation Salt; Excess
Interventions Furosemide 40 mg
Updated 16 times since 2018 Last updated: Oct 19, 2025 Started: Sep 1, 2021 Primary completion: Sep 1, 2026 Completion: Sep 15, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates High Blood Pressure and Inflammation and is currently ongoing. Vanderbilt University Medical Center leads this study, which shows 16 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Dec 2018 – ~May 2019 · 5 months · monthly snapshot~May 2019 – ~Oct 2020 · 17 months · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Apr 2021 · 59 days · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2022 · 13 months · monthly snapshot~Dec 2022 – ~Jan 2024 · 13 months · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Nov 2025 · 9 months · monthly snapshot~Nov 2025 – present · 8 months · monthly snapshot

Change History

16 versions recorded

  1. Nov 2025 — Present [monthly]

    Active Not Recruiting PHASE1/PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Feb 2025 — Nov 2025 [monthly]

    Recruiting PHASE1/PHASE2

  3. Sep 2024 — Feb 2025 [monthly]

    Recruiting PHASE1/PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  5. Jan 2024 — Jul 2024 [monthly]

    Recruiting PHASE1_PHASE2

▶ Show 11 earlier versions

  1. Dec 2022 — Jan 2024 [monthly]

    Recruiting PHASE1_PHASE2

  2. Nov 2021 — Dec 2022 [monthly]

    Recruiting PHASE1_PHASE2

  3. Oct 2021 — Nov 2021 [monthly]

    Recruiting PHASE1_PHASE2

  4. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE1_PHASE2

  5. Apr 2021 — Sep 2021 [monthly]

    Recruiting PHASE1_PHASE2

  6. Feb 2021 — Apr 2021 [monthly]

    Recruiting PHASE1_PHASE2

  7. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE1_PHASE2

  8. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

  9. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting

  10. May 2019 — Oct 2020 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  11. Dec 2018 — May 2019 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Vanderbilt University Medical Center
Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations